Apr 7, 2021, 01:00 by User Not Found

Clinical Research News | Janssen is using two homegrown data analytics solutions at scale to optimize clinical trials, enabling internal teams to solve real use cases embedded in the development process. The company is infusing real-world data (RWD) and data science into long-established processes to increase the operational success of trials and minimize patient burden.

Apr 6, 2021, 01:00 by User Not Found

Clinical Research News | A COVID-19 vaccine in one year is no small feat! What made it possible was the industry coming together in unprecedented ways and operating with a sense of urgency, spurring global cooperation for vaccine research, innovation, and distribution. We need to maintain this momentum at this critical junction, strengthen partnerships, and apply our learnings and knowledge to optimize clinical trials and accelerate the drug development process.

Apr 5, 2021, 14:49 by

THREAD, a technology and service provider enabling decentralized clinical trials (DCTs), today announced the launch of new telehealth features. Building on four years of conducting electronic clinical outcome assessments (eCOA) during telehealth virtual visits, the new features raise the bar in DCT telehealth functionality by adding several unique enhancements to the company’s industry-leading eCOA and telehealth virtual visit solution. New features allow clinical study stakeholders – including sponsors, caregivers, home health professionals and raters – to remotely and safely capture video and/or audio recordings in real time.

Apr 5, 2021, 14:49 by

Apr 5, 2021, 14:49 by

ENPICOM BV, an innovative bioinformatics software engineering company, has announced the approval of a joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application with Viroclinics-DDL, a state-of-the-art Contract Research Organization specialized in molecular diagnostic testing and assay development.

Apr 5, 2021, 14:49 by

Apr 5, 2021, 14:49 by

Thermo Fisher Scientific, which today announced their collaboration with Artificial to increase the productivity of COVID-19 testing through an integrated and comprehensive software automation platform.

Apr 5, 2021, 14:49 by

Apr 5, 2021, 14:49 by

Apr 5, 2021, 14:49 by

SignalChem Lifesciences, a clinical-stage company developing novel targeted therapies for oncology, has announced a collaboration with Merck, through a subsidiary, to evaluate the combination of SLC-391, a selective AXL inhibitor developed by SignalChem, with KEYTRUDA®, Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer (NSCLC).

Apr 5, 2021, 14:49 by

Panthera is enrolling Covid patients for AstraZeneca’s monoclonal antibody study to reduce disease severity

Apr 5, 2021, 14:49 by

Apr 5, 2021, 14:49 by

THREAD and Lokavant partner

Apr 5, 2021, 14:49 by

Apr 5, 2021, 14:49 by

Apr 5, 2021, 14:49 by

Vanessa Biotech has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the drug Shylicine™

Apr 5, 2021, 14:49 by

Apr 5, 2021, 14:49 by

Apr 5, 2021, 14:49 by

Apr 5, 2021, 14:49 by

Speaking at the ‘Innovative Chemistry for Peptide Manufacturing and Analysis’ conference, SB3000’s Chief R&D Officer Jens Bukrinski revealed that continuous manufacturing μLOT® technology could reduce the pharmaceutical industry’s use of toxic chemicals by 100 times.